WEST PHARMACEUTICAL SERVICES, INC. Restructuring and Related Cost, Incurred Cost
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Restructuring and Related Cost, Incurred Cost of $2.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. restructuring and related cost, incurred cost for the quarter ending 2026-06-30 was $2.30M, a 1050.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring and related cost, incurred cost for the quarter ending 2026-03-31 was $1.80M, a 89.02% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring and related cost, incurred cost for the quarter ending 2025-12-31 was $7.10M.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring and related cost, incurred cost for the quarter ending 2025-09-30 was $900.00K.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring and related cost, incurred cost for fiscal 2025 was $24.60M.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring and related cost, incurred cost for fiscal 2024 was -$2.50M.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring and related cost, incurred cost for fiscal 2023 was -$2.80M, a 111.76% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring and related cost, incurred cost for fiscal 2022 was $23.80M, a 981.82% increase from fiscal 2021.
| Period end | Restructuring and Related Cost, Incurred Cost 3 month | Restructuring and Related Cost, Incurred Cost 6 month | Restructuring and Related Cost, Incurred Cost 6 month as first filed | Restructuring and Related Cost, Incurred Cost 9 month | Restructuring and Related Cost, Incurred Cost 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.30M 10-Q · filed 2026-07-23 | $4.10M 10-Q · filed 2026-07-23 | $11.20M derived: sum of 3 quarters · filed 2026-07-23 | $12.10M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2026-03-31 | $1.80M 10-Q · filed 2026-04-23 | $8.90M derived: sum of 2 quarters · filed 2026-04-23 | $9.80M derived: sum of 3 quarters · filed 2026-04-23 | $10.00M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $8.00M derived: sum of 2 quarters · filed 2026-02-17 | $8.20M derived: sum of 3 quarters · filed 2026-07-23 | $24.60M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $900.00K 10-Q · filed 2025-10-23 | $1.10M derived: sum of 2 quarters · filed 2026-07-23 | $17.50M 10-Q · filed 2025-10-23 | $17.50M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-06-30 | $200.00K 10-Q · filed 2026-07-23 | $16.60M 10-Q · filed 2026-07-23 | $16.60M derived: sum of 3 quarters · filed 2026-07-23 | $14.10M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-03-31 | $16.40M 10-Q · filed 2026-04-23 | $16.40M derived: sum of 2 quarters · filed 2026-04-23 | $13.90M derived: sum of 3 quarters · filed 2026-04-23 | $13.90M derived: sum of 4 quarters · filed 2026-04-23 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$2.50M derived: sum of 2 quarters · filed 2026-02-17 | -$2.50M derived: sum of 3 quarters · filed 2026-02-17 | -$2.50M 10-K · filed 2026-02-17 | |
| 2024-09-30 | -$2.50M 10-Q · filed 2025-10-23 | -$2.50M derived: sum of 2 quarters · filed 2025-10-23 | -$2.50M 10-Q · filed 2025-10-23 | -$4.50M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-24 | $0.00 10-Q · filed 2025-07-24 | -$2.00M derived: sum of 3 quarters · filed 2026-02-17 | -$2.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-04-24 | -$2.00M derived: sum of 2 quarters · filed 2026-02-17 | -$2.00M derived: sum of 3 quarters · filed 2026-02-17 | -$2.80M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$2.00M derived: sum of 2 quarters · filed 2026-02-17 | -$2.80M derived: sum of 3 quarters · filed 2026-02-17 | -$2.80M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-26 | -$800.00K derived: sum of 2 quarters · filed 2024-07-25 | -$800.00K 10-Q · filed 2023-10-26 | ||
| 2023-06-30 | -$800.00K 10-Q · filed 2024-07-25 | -$800.00K 10-Q · filed 2024-07-25 | |||
| 2022-12-31 | $25.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $25.40M derived: sum of 2 quarters · filed 2025-02-18 | $23.80M derived: sum of 3 quarters · filed 2025-02-18 | $23.80M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-26 | -$1.60M derived: sum of 2 quarters · filed 2023-10-26 | -$1.60M 10-Q · filed 2023-10-26 | -$1.90M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-06-30 | -$1.60M 10-Q · filed 2023-07-27 | -$1.60M 10-Q · filed 2023-07-27 | -$1.90M derived: sum of 3 quarters · filed 2024-02-20 | -$1.50M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-28 | -$300.00K derived: sum of 2 quarters · filed 2024-02-20 | $100.00K derived: sum of 3 quarters · filed 2024-02-20 | $1.10M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2021-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $100.00K derived: sum of 2 quarters · filed 2024-02-20 | $1.10M derived: sum of 3 quarters · filed 2024-02-20 | $2.20M 10-K · filed 2024-02-20 | |
| 2021-09-30 | $400.00K 10-Q · filed 2022-10-27 | $1.40M derived: sum of 2 quarters · filed 2022-10-27 | $2.50M 10-Q · filed 2022-10-27 | $2.70M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-30 | $1.00M 10-Q · filed 2022-07-28 | $2.20M 10-Q · filed 2022-07-28 | $2.30M derived: sum of 3 quarters · filed 2023-02-21 | $6.80M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-03-31 | $1.20M 10-Q · filed 2022-04-28 | $1.30M derived: sum of 2 quarters · filed 2023-02-21 | $5.80M derived: sum of 3 quarters · filed 2023-02-21 | $5.80M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2020-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $4.60M derived: sum of 2 quarters · filed 2023-02-21 | $4.60M derived: sum of 3 quarters · filed 2023-02-21 | $4.60M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $4.50M 10-Q · filed 2021-10-28 | $4.50M derived: sum of 2 quarters · filed 2021-10-28 | $4.50M 10-Q · filed 2021-10-28 | $5.60M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-30 | $0.00 10-Q · filed 2021-07-30 | $1.10M derived: sum of 3 quarters · filed 2022-02-22 | $2.90M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-04-30 | $1.10M derived: sum of 2 quarters · filed 2022-02-22 | $2.90M derived: sum of 3 quarters · filed 2022-02-22 | $4.30M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2019-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $2.90M derived: sum of 2 quarters · filed 2022-02-22 | $4.30M derived: sum of 3 quarters · filed 2022-02-22 | $4.90M 10-K · filed 2022-02-22 | |
| 2019-09-30 | $1.80M 10-Q · filed 2020-10-23 | $3.20M derived: sum of 2 quarters · filed 2020-10-23 | $3.80M 10-Q · filed 2020-10-23 | $6.20M derived: sum of 4 quarters · filed 2021-02-23 | |
| 2019-06-30 | $1.40M 10-Q · filed 2019-07-29 | $2.00M 10-Q · filed 2019-07-29 | $4.40M derived: sum of 3 quarters · filed 2021-02-23 | $5.60M derived: sum of 4 quarters · filed 2021-02-23 | |
| 2019-03-31 | $600.00K 10-Q · filed 2019-05-08 | $3.00M derived: sum of 2 quarters · filed 2021-02-23 | $4.20M derived: sum of 3 quarters · filed 2021-02-23 | $6.40M derived: sum of 4 quarters · filed 2021-02-23 | |
| 2018-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $3.60M derived: sum of 2 quarters · filed 2021-02-23 | $5.80M derived: sum of 3 quarters · filed 2021-02-23 | $9.10M 10-K · filed 2021-02-23 | |
| 2018-09-30 | $1.20M 10-Q · filed 2018-10-30 | $3.40M derived: sum of 2 quarters · filed 2019-07-29 | $6.70M 10-Q · filed 2018-10-30 | $6.70M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | $2.20M 10-Q · filed 2019-07-29 | $5.50M 10-Q · filed 2019-07-29 | $5.50M derived: sum of 3 quarters · filed 2020-02-24 | $5.50M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | $3.30M 10-Q · filed 2019-05-08 | $3.30M derived: sum of 2 quarters · filed 2020-02-24 | $3.30M derived: sum of 3 quarters · filed 2020-02-24 | $3.30M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 10-K · filed 2020-02-24 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | $0.00 10-Q · filed 2018-10-30 | $2.70M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-07-31 | $0.00 10-Q · filed 2018-07-31 | $2.70M derived: sum of 3 quarters · filed 2019-02-28 | $5.00M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | $2.70M derived: sum of 2 quarters · filed 2019-02-28 | $5.00M derived: sum of 3 quarters · filed 2019-02-28 | $3.50M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $5.00M derived: sum of 2 quarters · filed 2019-02-28 | $3.50M derived: sum of 3 quarters · filed 2019-02-28 | $26.40M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $2.30M 10-Q · filed 2017-10-31 | $800.00K derived: sum of 2 quarters · filed 2017-10-31 | $23.70M 10-Q · filed 2017-10-31 | ||
| 2016-06-30 | -$1.50M 10-Q · filed 2017-08-01 | $21.40M 10-Q · filed 2017-08-01 | $22.90M 10-Q · filed 2016-08-01 | ||
| 2016-03-31 | $22.90M 10-Q · filed 2017-05-05 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-26 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |